National Health Commission of the People’s Republic of China [to 20 Nov 2021]

China CDC

National Health Commission of the People’s Republic of China [to 20 Nov 2021]
Nov 20: Daily briefing on novel coronavirus cases in China
On Nov 19, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 23 new cases of confirmed infections (20 imported cases, 6 in Shanghai municipality, 5 in Guangxi Zhuang autonomous region, 4 in Shandong province, 2 in Guangdong province, 2 in Yunnan province and 1 in Fujian province, including 1 confirmed case converting from an asymptomatic case in Guangdong; 3 indigenous cases, 2 in Dalian, Liaoning province and 1 in Jilin, Jilin province), no new cases of suspected infections, and no deaths…

National Medical Products Administration – PRC [to 20 Nov 2021]
COVID-19 vaccine doses administered on Chinese mainland hit 2.4b milestone
More than 2.4 billion doses of COVID-19 vaccines had been administered on the Chinese mainland as of Nov 16, data from the National Health Commission showed on Nov 17.

China, US need to initiate global public health, infectious disease response cooperation mechanism: Xi
President Xi Jinping on Tuesday said that China and the United States need to call for the establishment of a cooperation mechanism for global public health and communicable disease prevention and control, and promote further international exchanges and cooperation. Xi made the remarks in a virtual meeting with US President Joe Biden…

CCDC Weekly – Weekly Reports: Current Volume (3)
View  PDF of this issue
:: Foreword: World Antimicrobial Awareness Week 2021 — Spread Awareness, Stop Resistance
:: Preplanned Studies: Genomic Insight into the Antimicrobial Resistance of Streptococcus Suis — Six Countries, 2011–2019
:: Preplanned Studies: Prevalence of Escherichia coli and Antibiotic Resistance in Animal-Derived Food Samples — Six Districts, Beijing, China, 2020
:: Vital Surveillances: Surveillance of Multidrug-Resistant Bacterial Infections in Non-Adult Patients — Zhejiang Province, China, 2014–2019